Paul R. Edick, See Remarks at XERIS PHARMACEUTICALS INC (XERS), bought 33,000 shares at $3.00 ($99K) on 2020-05-08, disclosed to the SEC on 2020-05-11.
Recurring purchase ($99k) by See Remarks following this insider's established cadence. Pattern-driven, low signal.
Something here stands out, but not much.
| Filing → |
| XERS | BUY | 2022-05-13 | $140K | — | Filing → |
| XERS | BUY | 2021-11-16 | $46K | — | Filing → |
| XERS | BUY | 2021-11-12 | $416K | — | Filing → |